Biography
Dr. Rosenthal is a prolific author and a recipient of a number of professional honors and awards and is committed to clinical service, research and education. He has published numerous research articles on hepatitis. Currently, Dr. Rosenthal is pursuing research on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary disease, use of bioartificial liver support utilizing porcine hepatocytes for patients with fulminant liver failure, as well as researching the quality of life following liver transplantation in children.
Dr. Rosenthal’s professional services to the public include television, newspaper and radio interviews on various topics such as hepatitis A, B, and C, and liver transplants for local, national and international audiences. He is consultant to organizations such as the American Liver Foundation, Parents of Kids with Infectious Disease, the Centers for Disease Control and Prevention (CDC), and the National Institute of Health (NIH)
Education
| Institution | Degree | Dept or School | End Date |
|---|---|---|---|
| University of California | Diversity, Equity, and Inclusion Champion Training | 02/2021 | |
| SUNY Brooklyn | M.D. | School of Medicine | 1975 |
Board Certifications
American Board of Pediatrics, General Pediatrics
American Board of Pediatrics, Subspeciality in Pediatric Gastroenterology
American Board of Pediatrics, Certificate of Added Qualification in Transplant Hepatology
Awards & Honors
| Award | Conferred By | Date |
|---|---|---|
| Murray Davidson Award | American Academy of Pediatrics | 2013 |
| Chancellor's Award for Public Service | UCSF | 2002 |
Clinical Expertise
Acute Liver Failure
Biliary Atresia
Bioartificial Liver Support
Choledochal Cyst
Cirrhosis
Hepatitis B
Hepatitis C
Hepatocellular Carcinoma (Liver Cancer)
Live Donor Liver Transplantation
Liver Transplantation
Neonatal Hepatitis
Program Affiliations
UCSF Helen Diller Family Comprehensive Cancer Center
UCSF Liver Center
Pediatric Liver Transplant Program
Pediatric Intestinal Rehabilitation and Transplantation Program
In the News
Grants and Funding
- Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline | NIH | 2018-06-22 - 2028-06-30 | Role: Principal Investigator
- Childhood Liver Disease Research Network (ChiLDReN) - UCSF (CC) | NIH | 2002-09-15 - 2025-05-31 | Role: Principal Investigator
- Optimal chemopreventive regimens to prevent malaria and improve birth outcomes in Uganda | NIH | 2020-04-15 - 2025-03-31 | Role: Co-Principal Investigator
Research Narrative
Rosenthal is pursuing research on the pharmaceutical treatment of hepatitis B and C, genetics and immunology of biliary disease, use of bioartificial liver support utilizing porcine hepatocytes for patients with fulminant liver failure, as well as researching the quality of life following liver transplantation in children.
Clinical Research
Rosenthal is principal investigator on numerous clinical trials including the following:
- Tenofovir Alafenamide (TAF) in Adolescents With Chronic Hepatitis B Virus Infection
- NAFLD Pediatric Database 2
- A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects
- A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection
Research Interests
Bioartificial liver devices
Pediatric Acute Liver Failure (PALF)
Idiopathic neonatal hepatitis
Quality of life after liver transplants
Genetics and immunology of biliary atresia
Publications
- Demographic Factors and Biliary Atresia: A Childhood Liver Disease Research Network Study.| |
PubMed
- Secondary prophylaxis of variceal hemorrhage in biliary atresia-Analysis of prospective multicenter studies.| |
PubMed
- Prospective Multicenter Longitudinal Measurement of Liver Stiffness in School-Age Children With Cholestatic Liver Disease.| |
PubMed
- Long-term efficacy and safety of sofosbuvir-based direct-acting antiviral regimens in paediatric patients with hepatitis C virus infection: an international registry study.| |
PubMed
- Placental malaria induces a unique methylation profile associated with fetal growth restriction.| |
PubMed
- Increased serum GM-CSF at diagnosis of biliary atresia is associated with improved biliary drainage.| |
PubMed
- Systematic in vitro evolution in Plasmodium falciparum reveals key determinants of drug resistance.| |
PubMed
- Tambjamines as Fast-Acting Multistage Antimalarials.| |
PubMed
- Environmental toxicants modulate disease severity in pediatric metabolic dysfunction-associated steatohepatitis.| |
PubMed
- Gravidity influences distinct transcriptional profiles of maternal and fetal placental macrophages at term.| |
PubMed